Getting Pharmacogenomics Into the Clinic Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Wednesday, September 21, 2016

Getting Pharmacogenomics Into the Clinic



JAMA | JAMA Network

 Advocates of pharmacogenomics say the field is an emerging resource for improving patient safety. Since 2012, more than 1 million adverse drug events have been reported each year to the US Food and Drug Administration (FDA), “many of which might be preventable using PGx testing,” Geoffrey S. Ginsburg, MD, PhD, director of the Center for Applied Genomics and Precision Medicine at Duke University Medical Center, said in an email.

Ignite 

Patient Version

Clinicians

0 comments :

Post a Comment

Your comments?